arginyl-glycyl-aspartic acid has been researched along with Autoimmune Chronic Hepatitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aeed, H; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Shirin, H | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and Autoimmune Chronic Hepatitis
| Article | Year |
|---|---|
Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injury.
Topics: Animals; Carcinogens; Concanavalin A; Disease Progression; Guanidines; Hepatitis, Autoimmune; Liver Cirrhosis, Experimental; Mice; Mitogens; Oligopeptides; Rats; Receptors, Immunologic; T-Lymphocytes; Thioacetamide; Transaminases; Tumor Necrosis Factor-alpha; Valerates | 2000 |